Labao, Juliebeth .

HRN: 29-19-14  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/28/2026
CEFUROXIME 500MG (TAB)
07/28/2026
08/03/2026
PO
500 Mg
BID
Thinly MSAF
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: